BSE · BACPHAR
Bacil Pharma Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,621
of 5,004 stocks
🏆 New peak
▲ 1501W
Peak #3,621 · 01 Oct 2026
Bacil Pharma Ltd. is a microcap company in the Healthcare space and has a widely-held ownership base, with promoters at just 0%, trades at a moderate earnings multiple, and posts a modest return on equity.
Market Cap
36.42 Cr
P/E Ratio
23.49
P/B Ratio
0.62
ROE
6.27%
ROCE
3.99%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | Rs 0 | Rs 0 | Rs 0 | Rs 0 |
| Net Profit | -1.91 L | 62.16 L | 3.92 L | 1.38 L |
| EPS | 0.22 | 0.44 | 0.03 | 0.01 |
| Operating Profit | 6.64 L | -7.45 L | 3.92 L | -3.65 L |
Shareholding pattern
Promoter
0.00%
Public
100.00%
PUBLIC BREAKDOWN
Individuals
78.84%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Sep 2012 | Other | General |
| 12 Sep 2011 | Other | General |
| 09 Sep 2010 | Other | General |
| 10 Sep 2009 | Other | General |
| 11 Sep 2008 | Other | General |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.